Primary Site >> Esophagus Cancer
Gene >> FLT1
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. PMID: 12553021 |
Ref: Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer. PMID: 15750150 |
Ref: Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models. PMID: 16899606 |
Ref: Human esophageal cancer endothelial cells increase tumor growth by incorporating with mouse endothelium. PMID: 17276590 |
Ref: Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer. PMID: 18813825 |
Ref: Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements. PMID: 20720054 |
Ref: Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. PMID: 21951837 |
Ref: Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients. PMID: 24708624 Ref: Monitoring the early biologic response of esophageal carcinoma after irradiation with 18F-FLT: an in-vitro and in-vivo study. PMID: 25192190 |
Ref: Gradient-based delineation of the primary GTV on FLT PET in squamous cell cancer of the thoracic esophagus and impact on radiotherapy planning. PMID: 25572431 Ref: Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy. PMID: 25595897 |
Ref: Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers. PMID: 28078044 |
Ref: Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response. PMID: 29332233 Ref: MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer. PMID: 30245290 |